Results from a multicenter, randomized, double‐blind, placebo‐controlled study of repository corticotropin injection for multiple sclerosis relapse that did not adequately respond to corticosteroids

INTRODUCTION: About 20%–35% of multiple sclerosis (MS) patients fail to respond to high‐dose corticosteroids during a relapse. Repository corticotropin injection (RCI, Acthar(®) Gel) is a naturally sourced complex mixture of adrenocorticotropic hormone analogs and pituitary peptides that has anti‐in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wynn, Daniel, Goldstick, Lawrence, Bauer, William, Zhao, Enxu, Tarau, Eva, Cohen, Jeffrey A., Robertson, Derrick, Miller, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841301/
https://www.ncbi.nlm.nih.gov/pubmed/34984839
http://dx.doi.org/10.1111/cns.13789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841301/
https://www.ncbi.nlm.nih.gov/pubmed/34984839
http://dx.doi.org/10.1111/cns.13789

Ejemplares similares